Evidence map›Paper›PMID 28784698›Full record

ReviewJournal of the American Society of Nephrology : JASN2017

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Vasantha Jotwani, Mohamed G Atta, Michelle M Estrella

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Redefining therapeutic success in HIV patients: an expert view.The Journal of antimicrobial chemotherapy · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vasantha JotwaniKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, California.
Mohamed G AttaDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Michelle M EstrellaKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, California; michelle.estrella@ucsf.edu.
San Francisco VA Health Care System · USJohns Hopkins University · US

Funding

VIRAL PATHOGENESIS OF HIV ASSOCIATED NEPHROPATHYP01DK056492 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WYATT, CHRISTINA M · 1999 to 2021
$27.8M
Early-Stage Chronic Kidney Disease in HIV-infected IndividualsR01DA026770 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M · 2010 to 2020
$5.7M
Biomarkers of Kidney Injury to Predict AKI Onset and Progression in HIV InfectionR01DK103574 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI ESTRELLA, MICHELLE M · 2015 to 2020
$3.4M
Biomarkers of Drug-induced Kidney Injury in HIVK23DK109868 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOTWANI, VASANTHA KOLAVENNU · 2016 to 2020
$993k
NIDA NIH HHS R01 DA026770NIDDK NIH HHS K23 DK109868NIDDK NIH HHS P01 DK056492NIDDK NIH HHS R01 DK103574
6 · The paper itself

Abstract

In developed countries, remarkable advances in antiretroviral therapy have transformed HIV infection into a chronic condition. As a result, HIV-associated nephropathy, the classic HIV-driven kidney lesion among individuals of African descent, has largely disappeared in these regions. However, HIV-positive blacks continue to have much higher rates of ESRD than HIV-positive whites, which could be attributed to the

Indexed as

AIDS-Associated NephropathyAnti-Retroviral AgentsApolipoprotein L1ApolipoproteinsHIV InfectionsHumansKidney TransplantationLipoproteins, HDLRenal Insufficiency, ChronicRisk FactorsTenofovirAnti-Retroviral AgentsAPOL1 protein, humanApolipoprotein L1ApolipoproteinsLipoproteins, HDLTenofovirApolipoprotein L1chronic kidney diseaseHIV nephropathy

Identifiers

PMID28784698
PMCPMC5661296
OpenAlexW2744177985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.